t(8;14)(q24;q32) in two patients with CD10-negative primary thyroid diffuse large B-cell lymphoma

Nozomi Niitsu, Masataka Okamoto, Tadashi Yoshino, Hirokazu Nakamine, Naoya Nakamura, Masami Bessho, Masami Hirano, Ikuo Miura

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)


Diffuse large B-cell lymphoma (DLBCL) with the 8q24 translocation is occasionally seen in the gastrointestinal tract, but has rarely been reported in the thyroid gland. We experienced two cases of primary thyroid DLBCL having t(8;14)(q24;q32). The immunophenotype and karyotype of Case 1 (66-year-old female) and Case 2 (70-year-old female) were: CD10-, CD20+, BCL-2+/add(13)(q34), t(8;14)(q24;q32) and CD10-, CD20-, CD79a+, BCL-2-/t(8;14)(q24;q32), respectively. Although long-term complete remission could be achieved in both of our patients by conventional chemotherapy with/without radiation therapy, accumulation of further such cases is necessary to develop a standard treatment protocol and also to elucidate the pathogenesis of t(8;14)(q24;q32)-positive primary thyroid DLBCL.

Original languageEnglish
Pages (from-to)707-711
Number of pages5
JournalLeukemia Research
Issue number5
Publication statusPublished - 05-2007
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research


Dive into the research topics of 't(8;14)(q24;q32) in two patients with CD10-negative primary thyroid diffuse large B-cell lymphoma'. Together they form a unique fingerprint.

Cite this